Nationwide Study on Treatment of Mycotic Thoracic Aortic Aneurysms

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Objective/background: Mycotic aortic aneurysms are rare, life threatening, and complex. This nationwide study aimed to assess outcome after repair of mycotic thoracic aortic aneurysms (MTAAs). Methods: Patients treated in Sweden for MTAAs between 2000 and 2016 were identified in the Swedish vascular registry (2010–16) and local patient registries (2000–09). Primary outcome was survival, and secondary outcomes included surgical strategy, rate of infection related complications (IRC), and re-operations. Results: Fifty-two patients (median age 71 ± 8.1 years; 28 [54%] men, 13 [25%] ruptured) were identified (3.6% of all thoracic aortic aneurysm repairs in Sweden). Aneurysm location was aortic arch (n = 6; 11%), descending aorta (n = 42; 81%), and multiple locations (n = 4; 8%). Twenty-nine (56%) patients had positive cultures; the most prevalent agent was Staphylococcus aureus (n = 16; 31%). Operative techniques included thoracic endovascular aortic repair (TEVAR; n = 35 [67%]), fenestrated/branched TEVAR (n = 8; 15%), hybrid repair (n = 7; 14%), and open patch repair (n = 2; 4%). Survival was 92% (95% confidence interval [CI] 88–96) at 30 days, 88% (95% CI 84–93) at three months, 78% (73–84) at one year, and 71% (64–77) at five years. The mean follow up among survivors (> 90 days) was 45 months (range 4–216 months). Antibiotics were administered for a median of 15 weeks (range 0–220 weeks). IRCs occurred in nine patients (17%): sepsis (n = 3), graft infection (n = 3), recurrent mycotic aneurysm (n = 1), aorto-oesophageal/bronchial fistula (n = 2). Six (67%) IRCs were fatal; 80% occurred within the first year. Re-operations were performed in nine patients (17%). Conclusions: TEVAR was often used as treatment for MTAAs, with acceptable short- and long-term survival when compared with open cohorts in the literature. IRCs are of concern and warrant follow up and long-term antibiotic treatment.

Detaljer

Författare
  • K. Sörelius
  • A. Wanhainen
  • C. M. Wahlgren
  • M. Langenskiöld
  • H. Roos
  • T. Resch
  • R. Vaccarino
  • B. Arvidsson
  • P. Gillgren
  • L. Bilos
  • A. Pirouzram
  • M. Holsti
  • K. Mani
Enheter & grupper
Externa organisationer
  • Uppsala universitet, Historiska institutionen
  • Karolinska University Hospital
  • Sahlgrenska University Hospital
  • Linköping University
  • Karolinska Institute
  • Södersjukhuset
  • Örebro University Hospital
  • Norrland University Hospital
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Kardiologi
  • Kirurgi

Nyckelord

Originalspråkengelska
Sidor (från-till)239-246
TidskriftEuropean Journal of Vascular and Endovascular Surgery
Volym57
Utgivningsnummer2
StatusPublished - 2019
PublikationskategoriForskning
Peer review utfördJa